XLABNasdaqServices-Prepackaged SoftwareFiscal year ends June 30Also trades as XLABW

Exascale Labs Holdings Inc.

Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026

$3.06+0.71 (+30.21%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Exascale Labs Holdings Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30
Cash & Equivalents	2.69	4.23	0.97
Cash & Short-Term Investments	2.69	4.23	0.97
Receivables	1.15	0.15	–
Total Current Assets	6.52	7.30	–
Property, Plant & Equipment	0.01	0.02	–
Gross Property, Plant & Equipment	0.03	0.03	–
Total Assets	6.73	7.32	–
Accounts Payable	0.92	0.09	–
Total Current Liabilities	32	20	–
Total Liabilities	32	20	–
Common Stock	–	0.00	–
Additional Paid-In Capital	0.22	0.22	–
Retained Earnings	-25	-13	–
Shareholders' Equity	-25	-13	-5.49
Total Equity	-25	-13	-5.49
Total Liabilities & Equity	6.73	7.32	–
Shares Outstanding(shares)	–	0.00	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2026

Gross margin: 16.3%
Operating margin: -32.4%
Net margin: -82.1%
Return on equity, FY2026: 63.8%

Financial strength

Current ratio: 0.20
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 8.4%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –